Improved preclinical models. Clinically relevant predictions. Confidence in candidate progression. A transformed oncology pipeline.

“Excellent Tumor Models meeting that was very well attended. Great program, speakers and panelists, which made for productive discussions, networking and exchange of ideas” MedImmune

Building on the success of the inaugural Tumour Models London, the 2nd Annual meeting will revolutionise your approach to preclinical tumour modelling.

With an even greater focus on the challenges drug developers are currently struggling to overcome, Tumour Models London will give you the tools you need to develop and utilise the very best preclinical oncology models, operating within your cost and time restraints.

Bringing together an expert speaker panel from big and small pharma/biotech, this meeting will help you solve technical issues around how to:

• Optimise tumour models to make more clinically relevant predictions: Get the answers you need to overcome limitations with tumour models that you are currently using to test cancer drugs
• Integrate new models into drug discovery to ensure effective translation: Discover models with superior properties for predicting efficacy and mimicking tumour activity in patients
• Better analyse & interpret the data from your models to make better decisions: Find out what tools and procedures other drug developers are implementing to design accurate studies, visualise data easily and determine appropriate next steps
• With cutting edge data, exclusive research, opportunities to collaborate – this meeting is a must for those committed to bringing successful cancer drugs into the clinic.

Meet and network with large and small drug developers, cancer researchers, academics and leading model providers. Engage in high quality, scientific discussions and add valuable new contacts to your network.